Getinge AB ser. B
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It provides extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage so… Read more
Getinge AB ser. B (GETI-B) - Total Assets
Latest total assets as of December 2025: Skr56.51 Billion SEK
Based on the latest financial reports, Getinge AB ser. B (GETI-B) holds total assets worth Skr56.51 Billion SEK as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Getinge AB ser. B - Total Assets Trend (2002–2025)
This chart illustrates how Getinge AB ser. B’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Getinge AB ser. B - Asset Composition Analysis
Current Asset Composition (December 2025)
Getinge AB ser. B's total assets of Skr56.51 Billion consist of 30.5% current assets and 69.5% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr3.40 Billion | 6.0% |
| Accounts Receivable | Skr7.81 Billion | 13.8% |
| Inventory | Skr6.02 Billion | 10.7% |
| Property, Plant & Equipment | Skr4.94 Billion | 8.7% |
| Intangible Assets | Skr33.51 Billion | 59.3% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2002–2025)
This chart illustrates how Getinge AB ser. B's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Getinge AB ser. B's current assets represent 30.5% of total assets in 2025, a decrease from 51.2% in 2002.
- Cash Position: Cash and equivalents constituted 6.0% of total assets in 2025, up from 4.4% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 59.0% of total assets, an increase from 29.0% in 2002.
- Asset Diversification: The largest asset category is intangible assets at 59.3% of total assets.
Getinge AB ser. B Competitors by Total Assets
Key competitors of Getinge AB ser. B based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Getinge AB ser. B - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Getinge AB ser. B generates 0.62x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Getinge AB ser. B generates $ 4.00 in net profit.
Getinge AB ser. B - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.32 | 1.21 | 4.37 |
| Quick Ratio | 0.86 | 0.77 | 3.09 |
| Cash Ratio | 0.26 | 0.20 | 0.00 |
| Working Capital | Skr4.18 Billion | Skr 3.12 Billion | Skr 12.66 Billion |
Getinge AB ser. B - Advanced Valuation Insights
This section examines the relationship between Getinge AB ser. B's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.80 |
| Latest Market Cap to Assets Ratio | 0.05 |
| Asset Growth Rate (YoY) | -11.6% |
| Total Assets | Skr56.51 Billion |
| Market Capitalization | $3.03 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Getinge AB ser. B's assets below their book value (0.05 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Getinge AB ser. B's assets decreased by 11.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Getinge AB ser. B (2002–2025)
The table below shows the annual total assets of Getinge AB ser. B from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr56.51 Billion | -11.60% |
| 2024-12-31 | Skr63.92 Billion | +19.28% |
| 2023-12-31 | Skr53.59 Billion | +2.99% |
| 2022-12-31 | Skr52.03 Billion | +16.78% |
| 2021-12-31 | Skr44.55 Billion | -1.02% |
| 2020-12-31 | Skr45.01 Billion | +0.67% |
| 2019-12-31 | Skr44.71 Billion | +3.14% |
| 2018-12-31 | Skr43.35 Billion | +2.97% |
| 2017-12-31 | Skr42.10 Billion | -23.74% |
| 2016-12-31 | Skr55.21 Billion | +3.71% |
| 2015-12-31 | Skr53.23 Billion | +0.79% |
| 2014-12-31 | Skr52.82 Billion | +19.22% |
| 2013-12-31 | Skr44.30 Billion | +3.22% |
| 2012-12-31 | Skr42.92 Billion | +3.50% |
| 2011-12-31 | Skr41.47 Billion | +19.90% |
| 2010-12-31 | Skr34.59 Billion | -7.77% |
| 2009-12-31 | Skr37.50 Billion | +13.52% |
| 2008-12-31 | Skr33.03 Billion | +43.67% |
| 2007-12-31 | Skr22.99 Billion | +44.81% |
| 2006-12-31 | Skr15.88 Billion | +9.25% |
| 2005-12-31 | Skr14.53 Billion | +16.66% |
| 2004-12-31 | Skr12.46 Billion | +3.53% |
| 2003-12-31 | Skr12.03 Billion | +26.95% |
| 2002-12-31 | Skr9.48 Billion | -- |